We are at the forefront of bioanalytical innovation, offering a wide range of services, seamlessly supporting both small and large molecule drug development. For small molecules: Fit-for-purpose bioanalytical methods are developed for discovery studies. GLP-compliant bioanalysis using fully validated bioanalytical methods are performed for studies conducted for regulatory submission. Our team has extensive expertise in developing sensitive methods on LC-MS/MS platforms, including analysis of multi-analytes, metabolites, pro-drugs, and photo/temperature sensitive and ex-vivo unstable compounds. Analytical methods for new chemical entities are routinely established and validated. For large molecules: our team has immense experience in developing and validating sensitive and specific analytical/immunogenicity methods for different modalities such as peptides, enzymes, monoclonal antibodies, vaccines, and gene therapy products. These immunoanalytical methods are designed and optimized specifically to the requirements of your product. We are committed to delivering the highest quality data that meets stringent regulatory requirements. We operate under robust quality systems and adhere to global regulatory guidelines, ensuring data integrity and reliability for your programs. Contact us for your specific requirement – [email protected]